

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine secretion (GO:0090197) | 9.81858282 |
| 2 | regulation of chemokine secretion (GO:0090196) | 7.57681273 |
| 3 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 7.33599341 |
| 4 | * microglial cell activation (GO:0001774) | 7.25448152 |
| 5 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 7.05683500 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.50660742 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.29452209 |
| 8 | adenosine receptor signaling pathway (GO:0001973) | 6.28596564 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.26238626 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.08969387 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 6.08969387 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 6.08969387 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 6.08969387 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.08969387 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.08969387 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.02061850 |
| 17 | negative regulation of granulocyte differentiation (GO:0030853) | 5.90818997 |
| 18 | negative regulation of norepinephrine secretion (GO:0010700) | 5.85412955 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.83470785 |
| 20 | oligosaccharide catabolic process (GO:0009313) | 5.73463271 |
| 21 | purinergic receptor signaling pathway (GO:0035587) | 5.55686529 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.50351439 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 5.45800017 |
| 24 | chondroitin sulfate catabolic process (GO:0030207) | 5.34694310 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.97561652 |
| 26 | keratan sulfate catabolic process (GO:0042340) | 4.91514144 |
| 27 | glycolipid catabolic process (GO:0019377) | 4.89075721 |
| 28 | leukocyte aggregation (GO:0070486) | 4.84979477 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.81470182 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.80400695 |
| 31 | detection of other organism (GO:0098543) | 4.49590059 |
| 32 | ceramide catabolic process (GO:0046514) | 4.49121682 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 4.36243869 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.35004578 |
| 35 | detection of bacterium (GO:0016045) | 4.32420287 |
| 36 | monocyte differentiation (GO:0030224) | 4.31478827 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31125271 |
| 38 | hyaluronan catabolic process (GO:0030214) | 4.20857341 |
| 39 | * macrophage activation involved in immune response (GO:0002281) | 4.18998811 |
| 40 | * macrophage activation (GO:0042116) | 4.16956668 |
| 41 | response to interleukin-15 (GO:0070672) | 4.13384188 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 4.12726489 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.10089454 |
| 44 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.04544637 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.97288060 |
| 46 | I-kappaB phosphorylation (GO:0007252) | 3.97084584 |
| 47 | response to host (GO:0075136) | 3.96689413 |
| 48 | response to host defenses (GO:0052200) | 3.96689413 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96689413 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.95302214 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93980666 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.89415755 |
| 53 | response to peptidoglycan (GO:0032494) | 3.88386270 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.88342085 |
| 55 | positive regulation of mast cell degranulation (GO:0043306) | 3.86238937 |
| 56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.86238937 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.85633026 |
| 58 | negative thymic T cell selection (GO:0045060) | 3.85341573 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.84535700 |
| 60 | negative T cell selection (GO:0043383) | 3.84062476 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.82700628 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 3.79527001 |
| 63 | neutrophil activation (GO:0042119) | 3.78407867 |
| 64 | negative regulation of multicellular organism growth (GO:0040015) | 3.77894616 |
| 65 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.73791308 |
| 66 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.73791308 |
| 67 | lytic vacuole organization (GO:0080171) | 3.72483311 |
| 68 | lysosome organization (GO:0007040) | 3.72483311 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70170776 |
| 70 | response to host immune response (GO:0052572) | 3.70170776 |
| 71 | ruffle organization (GO:0031529) | 3.68526175 |
| 72 | regulation of macrophage chemotaxis (GO:0010758) | 3.65109680 |
| 73 | positive T cell selection (GO:0043368) | 3.63741334 |
| 74 | adaptation of signaling pathway (GO:0023058) | 3.63575465 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 3.60669091 |
| 76 | sodium-independent organic anion transport (GO:0043252) | 3.58163046 |
| 77 | positive thymic T cell selection (GO:0045059) | 3.57498059 |
| 78 | T cell migration (GO:0072678) | 3.54986706 |
| 79 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.54311931 |
| 80 | negative regulation of tissue remodeling (GO:0034104) | 3.52319249 |
| 81 | macrophage differentiation (GO:0030225) | 3.50965492 |
| 82 | negative regulation of catecholamine secretion (GO:0033604) | 3.50002386 |
| 83 | cyclooxygenase pathway (GO:0019371) | 3.49632496 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 3.49400679 |
| 85 | regulation of hypersensitivity (GO:0002883) | 3.46901512 |
| 86 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46860694 |
| 87 | detection of biotic stimulus (GO:0009595) | 3.46826654 |
| 88 | negative regulation of cell killing (GO:0031342) | 3.44385385 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.44385385 |
| 90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.44115310 |
| 91 | regulation of mast cell activation (GO:0033003) | 3.43074125 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.42916035 |
| 93 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.42112490 |
| 94 | phagocytosis, engulfment (GO:0006911) | 3.41383037 |
| 95 | negative regulation of bone resorption (GO:0045779) | 3.39319653 |
| 96 | T cell selection (GO:0045058) | 3.39056752 |
| 97 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.39036755 |
| 98 | granulocyte activation (GO:0036230) | 3.37859516 |
| 99 | tolerance induction (GO:0002507) | 3.37223405 |
| 100 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.36879194 |
| 101 | cell-cell junction maintenance (GO:0045217) | 3.35523236 |
| 102 | negative regulation of interleukin-6 production (GO:0032715) | 3.35414220 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.33756563 |
| 104 | positive regulation of B cell mediated immunity (GO:0002714) | 3.31520554 |
| 105 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.31520554 |
| 106 | ganglioside metabolic process (GO:0001573) | 3.30969885 |
| 107 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.29471425 |
| 108 | mannose metabolic process (GO:0006013) | 3.29439254 |
| 109 | negative regulation of phagocytosis (GO:0050765) | 3.26214526 |
| 110 | leukocyte degranulation (GO:0043299) | 3.23681939 |
| 111 | response to cholesterol (GO:0070723) | 3.23349592 |
| 112 | regulation of leukocyte degranulation (GO:0043300) | 3.21895468 |
| 113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.21053457 |
| 114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.18609731 |
| 115 | positive regulation of isotype switching (GO:0045830) | 3.18054432 |
| 116 | cellular extravasation (GO:0045123) | 3.17115030 |
| 117 | regulation of tolerance induction (GO:0002643) | 3.14340827 |
| 118 | response to type I interferon (GO:0034340) | 3.14065047 |
| 119 | glial cell migration (GO:0008347) | 3.13842272 |
| 120 | cellular response to type I interferon (GO:0071357) | 3.13747700 |
| 121 | type I interferon signaling pathway (GO:0060337) | 3.13747700 |
| 122 | myeloid leukocyte mediated immunity (GO:0002444) | 3.12239548 |
| 123 | T-helper 1 type immune response (GO:0042088) | 3.10745667 |
| 124 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.09596367 |
| 125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09435570 |
| 126 | mast cell activation (GO:0045576) | 3.07746574 |
| 127 | germ cell migration (GO:0008354) | 3.05376617 |
| 128 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.05235034 |
| 129 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04228135 |
| 130 | interferon-gamma production (GO:0032609) | 3.03787561 |
| 131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02685255 |
| 132 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.02601696 |
| 133 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.01960187 |
| 134 | negative regulation of B cell proliferation (GO:0030889) | 3.01342632 |
| 135 | B cell mediated immunity (GO:0019724) | 3.01316329 |
| 136 | histone H4-K12 acetylation (GO:0043983) | 3.00589176 |
| 137 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.00144048 |
| 138 | thymic T cell selection (GO:0045061) | 2.99586391 |
| 139 | regulation of monocyte differentiation (GO:0045655) | 2.96247624 |
| 140 | neutrophil mediated immunity (GO:0002446) | 2.93638086 |
| 141 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93192189 |
| 142 | regulation of monocyte chemotaxis (GO:0090025) | 2.88582767 |
| 143 | histamine secretion (GO:0001821) | 2.86214089 |
| 144 | regulation of granulocyte differentiation (GO:0030852) | 2.84833752 |
| 145 | negative regulation of smooth muscle contraction (GO:0045986) | 2.84315329 |
| 146 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.83135731 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 2.83023766 |
| 148 | Rac protein signal transduction (GO:0016601) | 2.79123054 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.78179317 |
| 150 | regulation of mast cell degranulation (GO:0043304) | 2.75315298 |
| 151 | neutrophil activation involved in immune response (GO:0002283) | 2.74254335 |
| 152 | response to laminar fluid shear stress (GO:0034616) | 2.71816541 |
| 153 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71569882 |
| 154 | sphingolipid catabolic process (GO:0030149) | 2.71286316 |
| 155 | positive regulation of chemokine production (GO:0032722) | 2.70820703 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.70529983 |
| 157 | * myeloid cell activation involved in immune response (GO:0002275) | 2.70390307 |
| 158 | regulation of norepinephrine secretion (GO:0014061) | 2.68398900 |
| 159 | response to sterol (GO:0036314) | 2.67870876 |
| 160 | negative regulation of bone remodeling (GO:0046851) | 2.67595227 |
| 161 | regulation of actin cytoskeleton reorganization (GO:2000249) | 2.65682495 |
| 162 | B cell receptor signaling pathway (GO:0050853) | 2.65356187 |
| 163 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.65202571 |
| 164 | activated T cell proliferation (GO:0050798) | 2.62201971 |
| 165 | regulation of B cell differentiation (GO:0045577) | 2.62199076 |
| 166 | respiratory burst (GO:0045730) | 2.61703239 |
| 167 | regulation of platelet aggregation (GO:0090330) | 2.61288821 |
| 168 | regulation of bone resorption (GO:0045124) | 2.60322645 |
| 169 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 11.1886916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.01103183 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.81473564 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.24668179 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77744935 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.18178892 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09830516 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.89777168 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.75789419 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70333769 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70115551 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48437470 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37444345 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37297750 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34850959 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31784361 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.21410092 |
| 17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18548015 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17036539 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.12594263 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11938396 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98504200 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91996798 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.91183554 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83001495 |
| 25 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81953103 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71245088 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.70735962 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65216363 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62552901 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59581463 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58388819 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56129656 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.55252179 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54253635 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52145375 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50868960 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50176078 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49442788 |
| 39 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48726012 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45623996 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41562113 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41334315 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40795219 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39864593 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39838572 |
| 46 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39042527 |
| 47 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.35916973 |
| 48 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.35916973 |
| 49 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.35916973 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32379535 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32019673 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30126113 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29865407 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29636189 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27445442 |
| 56 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26450379 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24200858 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23818648 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22755310 |
| 60 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21440523 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19693923 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19643376 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.19539240 |
| 64 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19055557 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18906105 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18381687 |
| 67 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17847107 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15745133 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15676846 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14891024 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13508776 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13047010 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12881876 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12122994 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10366394 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09299946 |
| 77 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08044433 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07901115 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07801165 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07343323 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04610396 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04453421 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04115894 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03311954 |
| 85 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03229943 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02826487 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00401607 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00227475 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00080939 |
| 90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99552092 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97640271 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97082277 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96003559 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95994063 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95112741 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94769150 |
| 97 | MYB_26560356_Chip-Seq_TH2_Human | 0.94604992 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94158883 |
| 99 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94107007 |
| 100 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93287332 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91825636 |
| 102 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.87243208 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87095214 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86535229 |
| 105 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86468812 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86162979 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84930766 |
| 108 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84783375 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84739956 |
| 110 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84114811 |
| 111 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.83760938 |
| 112 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83147865 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 0.82809584 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81600922 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81472743 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80436080 |
| 117 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.79724687 |
| 118 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.79724687 |
| 119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79633718 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79089130 |
| 121 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78627142 |
| 122 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78546426 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77980474 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77977666 |
| 125 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77521919 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76753333 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.76595790 |
| 128 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.76356507 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75670841 |
| 130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.75619559 |
| 131 | MYB_26560356_Chip-Seq_TH1_Human | 0.75612793 |
| 132 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.75022388 |
| 133 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74262480 |
| 134 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.74048267 |
| 135 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73932278 |
| 136 | GATA3_26560356_Chip-Seq_TH2_Human | 0.72541084 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72395312 |
| 138 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71971629 |
| 139 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71853481 |
| 140 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71581110 |
| 141 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.70068228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 6.62971109 |
| 2 | MP0005058_abnormal_lysosome_morphology | 5.35704333 |
| 3 | MP0003172_abnormal_lysosome_physiology | 4.57319147 |
| 4 | * MP0006082_CNS_inflammation | 3.71653144 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.64679962 |
| 6 | MP0005464_abnormal_platelet_physiology | 3.51558359 |
| 7 | MP0003303_peritoneal_inflammation | 3.15858910 |
| 8 | MP0003075_altered_response_to | 2.88150603 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.85199441 |
| 10 | MP0008004_abnormal_stomach_pH | 2.67609899 |
| 11 | * MP0009785_altered_susceptibility_to | 2.54372343 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.52379268 |
| 13 | MP0002132_abnormal_respiratory_system | 2.49061685 |
| 14 | * MP0003690_abnormal_glial_cell | 2.36557279 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.35529553 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.32833282 |
| 17 | MP0008260_abnormal_autophagy | 2.32059597 |
| 18 | * MP0005671_abnormal_response_to | 2.25074876 |
| 19 | MP0003045_fibrosis | 2.16031203 |
| 20 | MP0001851_eye_inflammation | 2.15070543 |
| 21 | * MP0002452_abnormal_antigen_presenting | 2.11532252 |
| 22 | MP0009840_abnormal_foam_cell | 2.09960948 |
| 23 | MP0002723_abnormal_immune_serum | 2.02018506 |
| 24 | MP0003252_abnormal_bile_duct | 1.99185352 |
| 25 | MP0005670_abnormal_white_adipose | 1.89025622 |
| 26 | MP0001800_abnormal_humoral_immune | 1.87989658 |
| 27 | MP0003436_decreased_susceptibility_to | 1.84541610 |
| 28 | MP0000343_altered_response_to | 1.82682660 |
| 29 | * MP0005000_abnormal_immune_tolerance | 1.82557566 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.82093542 |
| 31 | MP0003724_increased_susceptibility_to | 1.77526232 |
| 32 | MP0000858_altered_metastatic_potential | 1.76045088 |
| 33 | MP0003866_abnormal_defecation | 1.71608854 |
| 34 | MP0002090_abnormal_vision | 1.71496000 |
| 35 | * MP0001819_abnormal_immune_cell | 1.70679939 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.65471967 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.65390911 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.64338888 |
| 39 | MP0002928_abnormal_bile_duct | 1.63381975 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.61461464 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.57766790 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.55853248 |
| 43 | * MP0009333_abnormal_splenocyte_physiolog | 1.47195410 |
| 44 | MP0008469_abnormal_protein_level | 1.43255973 |
| 45 | MP0004381_abnormal_hair_follicle | 1.37018872 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.35063558 |
| 47 | MP0005310_abnormal_salivary_gland | 1.34059777 |
| 48 | * MP0005025_abnormal_response_to | 1.32684146 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.32018644 |
| 50 | MP0002254_reproductive_system_inflammat | 1.29382690 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.29169082 |
| 52 | MP0004510_myositis | 1.28500429 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.24027347 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.23753015 |
| 55 | MP0003633_abnormal_nervous_system | 1.20956643 |
| 56 | MP0000767_abnormal_smooth_muscle | 1.20132886 |
| 57 | MP0003279_aneurysm | 1.19681864 |
| 58 | MP0003828_pulmonary_edema | 1.18689776 |
| 59 | * MP0000716_abnormal_immune_system | 1.18130147 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.17860048 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.17856786 |
| 62 | MP0002405_respiratory_system_inflammati | 1.15564170 |
| 63 | MP0008874_decreased_physiological_sensi | 1.13493057 |
| 64 | MP0005165_increased_susceptibility_to | 1.10084163 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.07602661 |
| 66 | MP0002736_abnormal_nociception_after | 1.07093353 |
| 67 | MP0003448_altered_tumor_morphology | 1.05596658 |
| 68 | MP0009764_decreased_sensitivity_to | 1.04434918 |
| 69 | MP0001663_abnormal_digestive_system | 1.03525144 |
| 70 | MP0001790_abnormal_immune_system | 1.01417335 |
| 71 | MP0005387_immune_system_phenotype | 1.01417335 |
| 72 | MP0001542_abnormal_bone_strength | 1.01375556 |
| 73 | MP0002398_abnormal_bone_marrow | 1.00880061 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 0.99969259 |
| 75 | * MP0000920_abnormal_myelination | 0.99662433 |
| 76 | * MP0000249_abnormal_blood_vessel | 0.97860160 |
| 77 | MP0002722_abnormal_immune_system | 0.97469229 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.96785237 |
| 79 | MP0001545_abnormal_hematopoietic_system | 0.96785237 |
| 80 | * MP0005166_decreased_susceptibility_to | 0.96112496 |
| 81 | * MP0005164_abnormal_response_to | 0.95994727 |
| 82 | MP0002064_seizures | 0.93830675 |
| 83 | MP0005409_darkened_coat_color | 0.91939970 |
| 84 | MP0004130_abnormal_muscle_cell | 0.90340502 |
| 85 | MP0001853_heart_inflammation | 0.90247823 |
| 86 | * MP0002429_abnormal_blood_cell | 0.89298649 |
| 87 | * MP0009763_increased_sensitivity_to | 0.85520909 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.84590007 |
| 89 | MP0005451_abnormal_body_composition | 0.79920860 |
| 90 | MP0005390_skeleton_phenotype | 0.78677883 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.77804037 |
| 92 | * MP0003634_abnormal_glial_cell | 0.76640593 |
| 93 | MP0005023_abnormal_wound_healing | 0.75578971 |
| 94 | MP0002933_joint_inflammation | 0.74889351 |
| 95 | MP0004484_altered_response_of | 0.74229522 |
| 96 | MP0000685_abnormal_immune_system | 0.73201185 |
| 97 | MP0005647_abnormal_sex_gland | 0.72879777 |
| 98 | MP0003795_abnormal_bone_structure | 0.72345538 |
| 99 | MP0001873_stomach_inflammation | 0.72313172 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.71815792 |
| 101 | MP0009278_abnormal_bone_marrow | 0.71212963 |
| 102 | MP0002006_tumorigenesis | 0.70221697 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.66070578 |
| 104 | MP0001348_abnormal_lacrimal_gland | 0.65985028 |
| 105 | MP0001968_abnormal_touch/_nociception | 0.64449672 |
| 106 | MP0005535_abnormal_body_temperature | 0.64323065 |
| 107 | MP0003631_nervous_system_phenotype | 0.62958637 |
| 108 | MP0002557_abnormal_social/conspecific_i | 0.61386328 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.60863863 |
| 110 | MP0000604_amyloidosis | 0.60086889 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.59720734 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.59042773 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.58404640 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.57393141 |
| 115 | * MP0008873_increased_physiological_sensi | 0.57195394 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.56914412 |
| 117 | * MP0004883_abnormal_blood_vessel | 0.56345685 |
| 118 | MP0005083_abnormal_biliary_tract | 0.56189739 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.56086420 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.55968134 |
| 121 | MP0002135_abnormal_kidney_morphology | 0.54505651 |
| 122 | MP0004859_abnormal_synaptic_plasticity | 0.53566686 |
| 123 | MP0009053_abnormal_anal_canal | 0.53165336 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.52102067 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.51461167 |
| 126 | MP0004947_skin_inflammation | 0.50255690 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.49344116 |
| 128 | MP0000490_abnormal_crypts_of | 0.49033027 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.48733689 |
| 130 | MP0003879_abnormal_hair_cell | 0.48396014 |
| 131 | MP0002133_abnormal_respiratory_system | 0.44479638 |
| 132 | MP0005388_respiratory_system_phenotype | 0.44479638 |
| 133 | MP0003091_abnormal_cell_migration | 0.44152931 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.43085905 |
| 135 | MP0003787_abnormal_imprinting | 0.42664449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 9.47615364 |
| 2 | Glomerulonephritis (HP:0000099) | 8.44744463 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.53108368 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.53108368 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.53108368 |
| 6 | Complement deficiency (HP:0004431) | 6.43538588 |
| 7 | Arterial tortuosity (HP:0005116) | 5.95090838 |
| 8 | Mutism (HP:0002300) | 5.35101604 |
| 9 | Vascular tortuosity (HP:0004948) | 5.20487465 |
| 10 | Urethral obstruction (HP:0000796) | 5.04651722 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.76855513 |
| 12 | Orchitis (HP:0100796) | 4.73762854 |
| 13 | Retinal atrophy (HP:0001105) | 4.73367614 |
| 14 | Dysostosis multiplex (HP:0000943) | 4.63790260 |
| 15 | Cerebral aneurysm (HP:0004944) | 4.63426313 |
| 16 | Abnormality of complement system (HP:0005339) | 4.60350098 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.53543065 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.53543065 |
| 19 | Optic neuritis (HP:0100653) | 4.51256217 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 4.51256217 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 4.50743528 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.44247976 |
| 23 | Stomatitis (HP:0010280) | 4.43345486 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.24810792 |
| 25 | Abnormality of T cell number (HP:0011839) | 4.15725946 |
| 26 | Nephritis (HP:0000123) | 4.11811689 |
| 27 | Recurrent abscess formation (HP:0002722) | 4.10901100 |
| 28 | T lymphocytopenia (HP:0005403) | 4.10101416 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 3.99689234 |
| 30 | Meningitis (HP:0001287) | 3.90930202 |
| 31 | Encephalitis (HP:0002383) | 3.87344445 |
| 32 | Orthostatic hypotension (HP:0001278) | 3.83254009 |
| 33 | Chronic diarrhea (HP:0002028) | 3.81255408 |
| 34 | Aortic aneurysm (HP:0004942) | 3.79810964 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.77058644 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 3.71826821 |
| 37 | Hematochezia (HP:0002573) | 3.71159232 |
| 38 | Keratoconjunctivitis (HP:0001096) | 3.61914911 |
| 39 | Axonal loss (HP:0003447) | 3.55912261 |
| 40 | Disinhibition (HP:0000734) | 3.51292344 |
| 41 | Increased IgE level (HP:0003212) | 3.45845601 |
| 42 | Progressive neurologic deterioration (HP:0002344) | 3.45781355 |
| 43 | Agnosia (HP:0010524) | 3.37469383 |
| 44 | Vasculitis (HP:0002633) | 3.36829216 |
| 45 | Leukocytosis (HP:0001974) | 3.33971881 |
| 46 | Abnormality of T cells (HP:0002843) | 3.28091283 |
| 47 | Eczematoid dermatitis (HP:0000976) | 3.27304890 |
| 48 | Pustule (HP:0200039) | 3.25994313 |
| 49 | Impaired platelet aggregation (HP:0003540) | 3.24243895 |
| 50 | Abnormal platelet function (HP:0011869) | 3.24243895 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 3.23211788 |
| 52 | Hemiplegia (HP:0002301) | 3.21095727 |
| 53 | Gingivitis (HP:0000230) | 3.21002411 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.19583896 |
| 55 | Mucopolysacchariduria (HP:0008155) | 3.19583896 |
| 56 | Disproportionate tall stature (HP:0001519) | 3.18975532 |
| 57 | Recurrent viral infections (HP:0004429) | 3.13898059 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 3.09739830 |
| 59 | Hepatosplenomegaly (HP:0001433) | 3.09269584 |
| 60 | Partial duplication of thumb phalanx (HP:0009944) | 3.06323371 |
| 61 | Intestinal atresia (HP:0011100) | 3.04644697 |
| 62 | Chest pain (HP:0100749) | 3.04592446 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 3.04406998 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.03151557 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.03151557 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.03151557 |
| 67 | Colitis (HP:0002583) | 3.02635277 |
| 68 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01794620 |
| 69 | Granulocytopenia (HP:0001913) | 2.98417505 |
| 70 | Striae distensae (HP:0001065) | 2.97199351 |
| 71 | Upper motor neuron abnormality (HP:0002127) | 2.95841451 |
| 72 | Increased IgM level (HP:0003496) | 2.93812113 |
| 73 | Eosinophilia (HP:0001880) | 2.93802015 |
| 74 | Gingival bleeding (HP:0000225) | 2.93357968 |
| 75 | Spondylolisthesis (HP:0003302) | 2.91908739 |
| 76 | Aortic dissection (HP:0002647) | 2.91092799 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 2.90528940 |
| 78 | Urticaria (HP:0001025) | 2.88288223 |
| 79 | Rectovaginal fistula (HP:0000143) | 2.86121271 |
| 80 | Rectal fistula (HP:0100590) | 2.86121271 |
| 81 | Split foot (HP:0001839) | 2.85001463 |
| 82 | Hemoptysis (HP:0002105) | 2.81454687 |
| 83 | Intestinal fistula (HP:0100819) | 2.78459156 |
| 84 | Hypochromic anemia (HP:0001931) | 2.78247444 |
| 85 | Nasal polyposis (HP:0100582) | 2.78029387 |
| 86 | Cellulitis (HP:0100658) | 2.76938789 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.76359107 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.65831832 |
| 89 | Episodic fever (HP:0001954) | 2.62396852 |
| 90 | Partial duplication of the phalanx of hand (HP:0009999) | 2.61170799 |
| 91 | Lymphopenia (HP:0001888) | 2.60127358 |
| 92 | Arterial thrombosis (HP:0004420) | 2.58907384 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 2.57355885 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.56975167 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.56549355 |
| 96 | Anorexia (HP:0002039) | 2.56515601 |
| 97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.55509765 |
| 98 | Abnormality of eosinophils (HP:0001879) | 2.50469013 |
| 99 | Osteomyelitis (HP:0002754) | 2.50401101 |
| 100 | Arnold-Chiari malformation (HP:0002308) | 2.49674929 |
| 101 | J-shaped sella turcica (HP:0002680) | 2.48483896 |
| 102 | Vaginal fistula (HP:0004320) | 2.46312508 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.45440596 |
| 104 | Peritonitis (HP:0002586) | 2.44630498 |
| 105 | Cardiomegaly (HP:0001640) | 2.41707732 |
| 106 | Inflammation of the large intestine (HP:0002037) | 2.40568858 |
| 107 | Pulmonary embolism (HP:0002204) | 2.40087517 |
| 108 | Autoimmune thrombocytopenia (HP:0001973) | 2.36013552 |
| 109 | Amyloidosis (HP:0011034) | 2.35123501 |
| 110 | Purpura (HP:0000979) | 2.32482957 |
| 111 | Pathologic fracture (HP:0002756) | 2.30359781 |
| 112 | Papilledema (HP:0001085) | 2.28618447 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 2.27701802 |
| 114 | Lower limb asymmetry (HP:0100559) | 2.26205424 |
| 115 | Recurrent skin infections (HP:0001581) | 2.24189958 |
| 116 | Inappropriate behavior (HP:0000719) | 2.17764116 |
| 117 | Vertigo (HP:0002321) | 2.17067473 |
| 118 | Thoracic kyphosis (HP:0002942) | 2.15059795 |
| 119 | Gastrointestinal inflammation (HP:0004386) | 2.15048935 |
| 120 | Recurrent bronchitis (HP:0002837) | 2.14513700 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08461773 |
| 122 | Sepsis (HP:0100806) | 2.05590166 |
| 123 | Postural instability (HP:0002172) | 2.04379454 |
| 124 | Keratitis (HP:0000491) | 2.04017765 |
| 125 | Exotropia (HP:0000577) | 2.03876119 |
| 126 | Basal ganglia calcification (HP:0002135) | 2.03275908 |
| 127 | Urinary incontinence (HP:0000020) | 2.01429363 |
| 128 | Mitral valve prolapse (HP:0001634) | 2.01244826 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.01061870 |
| 130 | IgM deficiency (HP:0002850) | 2.00552197 |
| 131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99749315 |
| 132 | Joint swelling (HP:0001386) | 1.99482170 |
| 133 | Petechiae (HP:0000967) | 1.99347843 |
| 134 | Gangrene (HP:0100758) | 1.99013465 |
| 135 | Increased serum ferritin (HP:0003281) | 1.98214482 |
| 136 | Cheilitis (HP:0100825) | 1.97858767 |
| 137 | Dementia (HP:0000726) | 1.95620638 |
| 138 | Obstructive sleep apnea (HP:0002870) | 1.94226662 |
| 139 | Erectile abnormalities (HP:0100639) | 1.90613445 |
| 140 | Stomach cancer (HP:0012126) | 1.89169665 |
| 141 | Thick nail (HP:0001805) | 1.88921671 |
| 142 | Increased CSF protein (HP:0002922) | 1.88435616 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.88189124 |
| 144 | Thickened calvaria (HP:0002684) | 1.87684296 |
| 145 | Myositis (HP:0100614) | 1.86922087 |
| 146 | Microcytic anemia (HP:0001935) | 1.86564755 |
| 147 | Lymphoma (HP:0002665) | 1.86392717 |
| 148 | Verrucae (HP:0200043) | 1.86041725 |
| 149 | Papilloma (HP:0012740) | 1.86041725 |
| 150 | Abnormality of macrophages (HP:0004311) | 1.85997062 |
| 151 | Skin ulcer (HP:0200042) | 1.85050718 |
| 152 | Abnormality of the endocardium (HP:0004306) | 1.84375786 |
| 153 | Abnormality of the pericardium (HP:0001697) | 1.83402993 |
| 154 | Abnormality of the peritoneum (HP:0002585) | 1.82279765 |
| 155 | Slow saccadic eye movements (HP:0000514) | 1.82203994 |
| 156 | Polygenic inheritance (HP:0010982) | 1.80269218 |
| 157 | Progressive visual loss (HP:0000529) | 1.78699035 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.78418079 |
| 159 | Epistaxis (HP:0000421) | 1.77783808 |
| 160 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76310365 |
| 161 | Macroglossia (HP:0000158) | 1.74213284 |
| 162 | Prolonged bleeding time (HP:0003010) | 1.73611054 |
| 163 | Peripheral demyelination (HP:0011096) | 1.73154737 |
| 164 | Camptodactyly of toe (HP:0001836) | 1.69471177 |
| 165 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.69093094 |
| 166 | Joint stiffness (HP:0001387) | 1.67079301 |
| 167 | Spontaneous hematomas (HP:0007420) | 1.66378318 |
| 168 | Clumsiness (HP:0002312) | 1.65143709 |
| 169 | Bone pain (HP:0002653) | 1.63182495 |
| 170 | Anal stenosis (HP:0002025) | 1.59366946 |
| 171 | Apathy (HP:0000741) | 1.55959908 |
| 172 | Preauricular pit (HP:0004467) | 1.53320825 |
| 173 | Periauricular skin pits (HP:0100277) | 1.53320825 |
| 174 | Flared iliac wings (HP:0002869) | 1.52972769 |
| 175 | Bicuspid aortic valve (HP:0001647) | 1.52772901 |
| 176 | Obstructive lung disease (HP:0006536) | 1.49835051 |
| 177 | Chronic obstructive pulmonary disease (HP:0006510) | 1.49835051 |
| 178 | Gastrointestinal atresia (HP:0002589) | 1.49225215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 8.71924356 |
| 2 | MAPK15 | 5.21598889 |
| 3 | GRK7 | 4.64261810 |
| 4 | CSF1R | 3.58816007 |
| 5 | PDK2 | 3.36316610 |
| 6 | BLK | 2.76834407 |
| 7 | TSSK6 | 2.44529260 |
| 8 | TYK2 | 2.27970333 |
| 9 | RIPK4 | 2.26244236 |
| 10 | TNK2 | 1.92530394 |
| 11 | PRPF4B | 1.88383400 |
| 12 | NEK9 | 1.77226456 |
| 13 | MAPK12 | 1.75063333 |
| 14 | GRK6 | 1.74732287 |
| 15 | CAMK1D | 1.68128583 |
| 16 | JAK3 | 1.67987283 |
| 17 | STK10 | 1.64370205 |
| 18 | MATK | 1.60081865 |
| 19 | PAK4 | 1.59801446 |
| 20 | MOS | 1.55937003 |
| 21 | MAPK7 | 1.51207429 |
| 22 | TAOK3 | 1.50627338 |
| 23 | CLK1 | 1.48019419 |
| 24 | IRAK4 | 1.42526370 |
| 25 | CAMK1G | 1.37167516 |
| 26 | TXK | 1.33542507 |
| 27 | JAK1 | 1.32340347 |
| 28 | AKT3 | 1.29738078 |
| 29 | VRK1 | 1.29121641 |
| 30 | MAP3K11 | 1.27933692 |
| 31 | NEK6 | 1.26129557 |
| 32 | GRK5 | 1.21394724 |
| 33 | MAP3K3 | 1.17085687 |
| 34 | ADRBK2 | 1.16494981 |
| 35 | FES | 1.16273091 |
| 36 | TBK1 | 1.16207467 |
| 37 | PASK | 1.15796940 |
| 38 | TEC | 1.13924667 |
| 39 | PRKD2 | 1.12101009 |
| 40 | MAP4K1 | 1.10571330 |
| 41 | CDK3 | 1.08841022 |
| 42 | HCK | 1.04585900 |
| 43 | ERN1 | 1.04547667 |
| 44 | IRAK3 | 1.03150168 |
| 45 | ZAP70 | 1.01510043 |
| 46 | TAOK1 | 1.01028425 |
| 47 | CSK | 1.00755027 |
| 48 | SGK2 | 0.96708888 |
| 49 | KIT | 0.96652976 |
| 50 | PDK1 | 0.96293009 |
| 51 | PAK2 | 0.94594864 |
| 52 | MAP3K9 | 0.94362500 |
| 53 | ITK | 0.94349701 |
| 54 | SGK3 | 0.92186546 |
| 55 | LYN | 0.90280000 |
| 56 | MAP3K7 | 0.89539192 |
| 57 | CDK8 | 0.86262927 |
| 58 | PIM1 | 0.85886670 |
| 59 | TESK2 | 0.85104316 |
| 60 | CAMKK2 | 0.83148192 |
| 61 | PTK2B | 0.82703815 |
| 62 | MAP3K1 | 0.81674228 |
| 63 | LRRK2 | 0.80785232 |
| 64 | CAMKK1 | 0.79081962 |
| 65 | KSR2 | 0.78549982 |
| 66 | IKBKB | 0.78534713 |
| 67 | PRKCH | 0.78486878 |
| 68 | JAK2 | 0.78289015 |
| 69 | KSR1 | 0.76519306 |
| 70 | SIK2 | 0.76263765 |
| 71 | LCK | 0.74526398 |
| 72 | MAP3K13 | 0.73460138 |
| 73 | HIPK2 | 0.72089398 |
| 74 | MARK2 | 0.71053961 |
| 75 | PDPK1 | 0.69306697 |
| 76 | PRKCQ | 0.69054995 |
| 77 | MAPKAPK5 | 0.68502282 |
| 78 | CAMK4 | 0.64999495 |
| 79 | EPHB1 | 0.64699082 |
| 80 | MAP3K14 | 0.61411591 |
| 81 | IGF1R | 0.60277196 |
| 82 | PIK3CG | 0.59737919 |
| 83 | SYK | 0.58955281 |
| 84 | FGFR3 | 0.56665450 |
| 85 | MAPKAPK2 | 0.55090089 |
| 86 | TAF1 | 0.54779047 |
| 87 | MAP3K2 | 0.53309571 |
| 88 | MAP2K3 | 0.52698194 |
| 89 | EIF2AK2 | 0.52607626 |
| 90 | SIK3 | 0.52171835 |
| 91 | PKN1 | 0.51975903 |
| 92 | NLK | 0.51229880 |
| 93 | MAP2K4 | 0.49795149 |
| 94 | SGK223 | 0.49602738 |
| 95 | SGK494 | 0.49602738 |
| 96 | IRAK1 | 0.48283006 |
| 97 | CDK19 | 0.48275780 |
| 98 | EEF2K | 0.46189956 |
| 99 | PKN2 | 0.46153446 |
| 100 | RIPK1 | 0.43598156 |
| 101 | CDK6 | 0.43585724 |
| 102 | CDK4 | 0.42894986 |
| 103 | FGFR4 | 0.42725083 |
| 104 | PRKAA2 | 0.42573512 |
| 105 | MELK | 0.41693045 |
| 106 | FGR | 0.41421247 |
| 107 | ARAF | 0.41135981 |
| 108 | CDC42BPA | 0.39691238 |
| 109 | MAP2K6 | 0.39513092 |
| 110 | STK11 | 0.39465964 |
| 111 | INSR | 0.39013079 |
| 112 | CDK9 | 0.38351693 |
| 113 | STK38 | 0.37296920 |
| 114 | RET | 0.37194111 |
| 115 | EPHA3 | 0.36963607 |
| 116 | YES1 | 0.36008134 |
| 117 | RPS6KA2 | 0.34749627 |
| 118 | GSK3A | 0.34543136 |
| 119 | DYRK1B | 0.31649843 |
| 120 | ILK | 0.31635382 |
| 121 | BMPR2 | 0.30876421 |
| 122 | TRIB3 | 0.30787345 |
| 123 | PTK6 | 0.30213103 |
| 124 | PRKD1 | 0.30210396 |
| 125 | MAPK4 | 0.30151836 |
| 126 | PRKCZ | 0.30148674 |
| 127 | BRAF | 0.29715640 |
| 128 | PRKG1 | 0.28810936 |
| 129 | IKBKE | 0.27466403 |
| 130 | EGFR | 0.27133537 |
| 131 | KDR | 0.27116373 |
| 132 | BTK | 0.27066385 |
| 133 | MARK3 | 0.23961139 |
| 134 | IRAK2 | 0.23572795 |
| 135 | BMPR1B | 0.23017929 |
| 136 | CAMK1 | 0.22813663 |
| 137 | MAP2K2 | 0.22021568 |
| 138 | FYN | 0.20564831 |
| 139 | DMPK | 0.20385155 |
| 140 | RPS6KA6 | 0.19116791 |
| 141 | TRPM7 | 0.18410986 |
| 142 | MAP3K6 | 0.18293659 |
| 143 | RPS6KL1 | 0.17953989 |
| 144 | RPS6KC1 | 0.17953989 |
| 145 | RPS6KA4 | 0.16382870 |
| 146 | MAPKAPK3 | 0.16123708 |
| 147 | ICK | 0.15414254 |
| 148 | PRKCD | 0.15279563 |
| 149 | INSRR | 0.14628152 |
| 150 | ABL1 | 0.14174428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.69257609 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.67896108 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.54343019 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.34014858 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.92024977 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.87897539 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.59955775 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55700126 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49692885 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.47222875 |
| 11 | Prion diseases_Homo sapiens_hsa05020 | 2.17991731 |
| 12 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.07422951 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02161243 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98563755 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86756053 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.85096638 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75271675 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67870693 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62275177 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44621357 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41035914 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33928330 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.27918795 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.21325250 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21079157 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18568271 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.13831406 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13211900 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12333643 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11617567 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10133544 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08519458 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05136335 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02779190 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95452644 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 0.95389270 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95206026 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91513278 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 0.89299995 |
| 40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87988545 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.86187894 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 0.85354102 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.84463380 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84434348 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83651295 |
| 46 | Endocytosis_Homo sapiens_hsa04144 | 0.81797148 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80793797 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.79869002 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79598385 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.78965627 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78324041 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75400422 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73495104 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73180354 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72599907 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71762914 |
| 57 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71448130 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.71282434 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68818621 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68408749 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66940267 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66608350 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65178312 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.65024196 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.63202219 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62655966 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62647875 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62599790 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60273009 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59461544 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59316635 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.59018633 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58112835 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57455107 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57066981 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56300204 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.55855158 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55852470 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55170733 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54515618 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54216342 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53637906 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52379300 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52106164 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51776640 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51741533 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51732078 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51541612 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51151655 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50622097 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50160609 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50100830 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49486466 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48717108 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47788939 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.47576724 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.45427758 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43869575 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43812999 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43729820 |
| 101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43545681 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42813089 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40037414 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38866397 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37529358 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37431454 |
| 107 | Long-term depression_Homo sapiens_hsa04730 | 0.36389078 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35529472 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35461649 |
| 110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35361203 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34935702 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34884812 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.34718208 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.34697175 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33696564 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33306413 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33099466 |
| 118 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32887462 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32075646 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.32050061 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31309309 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31272737 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31099797 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30201622 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29699971 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29639255 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28698221 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.28617475 |

